Home › Funds › Jupiter Topco LLC › ASND
Jupiter Topco LLC position in ASND
ASCENDIS PHARMA A/S · Health Care
Jupiter Topco LLC reported holding 3,648,772 shares of ASND (ASCENDIS PHARMA A/S) in its Q2 2026 13F filing — a position valued at US$973.4M, representing 0.40% of its reported portfolio and ranking #47 among its reported holdings. Jupiter Topco LLC first reported this position in Q2 2026.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How Jupiter Topco LLC's ASND position evolved
Jupiter Topco LLC first disclosed a stake in ASND in Q2 2026 at 3,648,772 shares (US$973.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 3.65M | $973.38M | New |
About ASND and 13F data
ASND (ASCENDIS PHARMA A/S) is a Health Care company. 42 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ASND
- RA CAPITAL MANAGEMENT, L.P. 10.28M sh · $2.74B · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.75M sh · $1.80B · Q2 2026
- Avoro Capital Advisors LLC 5.11M sh · $1.36B · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 4.80M sh · $1.28B · Q2 2026
- Artisan Partners Limited Partnership 2.63M sh · $702.55M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.16M sh · $310.39M · Q2 2026
- Vestal Point Capital, LP 375.00K sh · $100.02M · Q2 2026
- Tri Locum Partners LP 258.74K sh · $69.01M · Q2 2026
- ORBIMED ADVISORS LLC 244.46K sh · $65.20M · Q2 2026
- PFM Health Sciences, LP 233.17K sh · $62.19M · Q2 2026
- Frazier Life Sciences Management, L.P. 225.16K sh · $60.05M · Q2 2026
- Spyglass Capital Management LLC 215.40K sh · $57.45M · Q2 2026
More on Jupiter Topco LLC
FAQ
How long has Jupiter Topco LLC held ASND?
Jupiter Topco LLC has disclosed ASND holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Jupiter Topco LLC's current position in ASND?
As of Q2 2026, Jupiter Topco LLC holds 3.65M shares of ASND (ASCENDIS PHARMA A/S), valued at $973.38M, representing 0.40% of its reported portfolio and ranking #47.
Has Jupiter Topco LLC been buying or selling ASND?
In the latest 13F filing (Q2 2026), Jupiter Topco LLC newly opened its position in ASND.
Which other funds hold ASND?
Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.